CLINICAL ROLE -
FDA Approves Dedicated Syringe for Humulin R U-500 Insulin
Humulin R U-500 has been approved since 1994 for the treatment of diabetes, but a dedicated syringe did not previously exist.
Read More
Model Predicts Medication Nonadherence in Glaucoma Patients
Patients who received their prescriptions by mail were the least likely to be adherent.
CRISPR/Cas9 Awakens Silenced Genes
Study reveals untapped potential of gene-editing tool.
Pesticides Associated with Environmentally-Linked Parkinson's Disease
Animal models exposed to the pesticide ziram formed clumps of a protein that damaged neurons and resulted in a Parkinson’s-like condition.
Trending News Today: Advocates Push for Manufacturers to Limit High Drug Pricing
Top news of the day from across the health care landscape.
Bacterial Microbes Linked to Head and Neck Cancer
Certain bacterial populations are increased or decreased in the presence of cancer.
Opioid-Free Anesthesia Leads to Less Pain Medication Use After Breast Cancer Surgery
After breast cancer surgery, patients who received non-opiate analgesia used less painkilling medication than patients who received opiate analgesia.
Genetic Marker May Improve Targeted Therapies for Acute Myeloid Leukemia
A majority of patients with specific gene mutation will eventually relapse and die of treatment-resistant leukemia.
Trending News Today: Aetna-Humana Merger Could Limit Medicare Advantage Plan Choices
Top news of the day from across the healthcare landscape.
FDA Approves Pharmaceutical Cannabinoid for Disease-Related Anorexia
Syndros treats anorexia related to AIDS and cancer patients experiencing nausea and vomiting due to chemotherapy.
Pharmaceutical Cannabinoid Approved for AIDS-Related Anorexia, Nausea from Chemotherapy
Syndros can be used to treat anorexia due to AIDS, and nausea and vomiting due to chemotherapy.
BRCA1 Vital to Gene Repair in Cancer
Genetic changes to BRCA1 predicts higher risk of breast and ovarian cancers.
Tired of Wearing Reading Glasses? There's a New Device for That
The FDA recently approved a device implanted in the cornea of one eye to improve near vision in certain patients with presbyopia.
Who Benefits from the Pharmacy School Bubble?
The pitfalls of a pharmacist surplus have been clearly outlined, but several types of individuals and institutions may benefit from having more pharmacists in the marketplace.
Model Predicts Risk of Invasive Breast Cancer
Treating modifiable risk factors could enhance breast cancer prevention.
Syndros Approved for AIDS-Related Anorexia
The FDA has approved Insys Therapeutics Inc's oral solution, Syndros, which is a liquid formulation of the pharmaceutical cannabinoid dronabinol.
Bausch + Lomb Introduces Enhanced Online Rebate Program
Nationwide Retailers Supporting Heart Health Through American Heart Association Point-of-Purchase Fundraising Campaign
Focus on Value, and Growth Will Follow
HRSA Wants to Audit Your 340B Program. Are You Ready? 5 Best Practices for Operating a Compliant 340B Program
It's Friday afternoon and your hospital receives an e-mail from the Health Resources and Services Administration, notifying you that your hospital has been selected for a 340B program audit. Are you ready?
Stiff Competition to Create a Smarter Inhaler
3M Drug Delivery Systems will be working to introduce its Intelligent Inhaler to the market by developing a partnership with pharmaceutical companies.
New Advancement in Automated Medication Dispensing and Ordering
Pillo is a slightly creepy-looking form of artificial intelligence that uses facial recognition to dispense medication and apparently also automatically reorder medicine before it runs out.
Obtaining a Best Possible Medication History in Hospitals
Completing a best possible medication history is a crucial first step in the medication reconciliation process.
Rising Drug Cost Controversy Highlights AJPB Week in Review
Top articles of the week from The American Journal of Pharmacy Benefits.
Sleep Apnea Associated with Cognitive Dysfunction in Multiple Sclerosis Patients
Obstructive sleep apnea in MS patients can lead to deeper problems.
Pre-Treatment Anti-Nausea Medication May Improve Liver Cancer Treatment
Anti-nausea and vomit medication could help reduce hospitalization in liver cancer.
Alabama Budget Crisis Leads to Medicaid Cuts
Physicians caring for Medicaid patients will no longer receive payment bumps.
Neurological Problems Common in Early HIV Infection
Antiretroviral therapy may alleviate some cognitive problems among HIV-positive patients.
FDA Tabs Director for New Oncology Center in Top Cancer News
Recent advances and updates in oncology and cancer drug development.
Twice Daily Therapy as Effective as Once Daily Treatment in Small Cell Lung Cancer
Patients receiving radiotherapy twice per day had a 2-year survival of 56% versus 51% in patients receiving treatment once per day.